Brief: Spago Nanomedical: SpagoPix Shows Good Safety In Regulatory Preclinical Studies
May 24 (Reuters) - SPAGO NANOMEDICAL AB (PUBL) SPAGO.TE :
* SPAGOPIX SHOWS GOOD SAFETY IN REGULATORY PRECLINICAL
STUDIES
* COMPLETED IN-LIFE PART OF REGULATORY PRECLINICAL PROGRAM
WITH
SPAGOPIX
Source text for Eikon: ID:nWkr98Tywh
Further company coverage: SPAGO.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose